Chris Wagner

Chris Wagner is the Chief Executive Officer and Co-Founder of Eden Radioisotopes, a company focused on the production of medical isotopes. He has over 40 years of extensive experience in the medical imaging industry, having held various senior executive roles that emphasize sales, marketing, and operational management.

Professional Background

• Current Role: As CEO since July 2021, Wagner leads Eden Radioisotopes in its mission to become the primary U.S. domestic producer of medical isotopes, ensuring a reliable supply for over 40 million patients worldwide.1
• Previous Experience: Before his current position, he served as Chief Operating Officer at Eden Radioisotopes from 2013 to 2021. He has also held significant roles at Nordion and Mallinckrodt Pharmaceuticals, managing nuclear medicine businesses and overseeing substantial P&L responsibilities.124

Education

Wagner holds a Bachelor of Science in Nuclear Medicine from Otterbein College and has pursued further studies in leadership and radiology from prestigious institutions, including Harvard Law School and The Ohio State University.1

Skills and Competencies

His core competencies include:

• Executive Leadership: Proven ability to lead organizations through strategic initiatives.
• Global Healthcare Experience: Extensive knowledge of the healthcare landscape, particularly in medical imaging.
• Strategic Business Development: Expertise in market assessment, sales projections, and building relationships with governmental entities.14

Wagner's leadership is pivotal in advancing Eden Radioisotopes' goals, particularly as the company works on establishing a new production facility for clinical radioisotopes in New Mexico.23